Rabbit Polyclonal p19 INK4d antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human Cyclin-dependent kinase 4 inhibitor D aa 50-150.
View Alternative Names
Cyclin-dependent kinase 4 inhibitor D, p19-INK4d, CDKN2D
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-p19 INK4d antibody (AB262871)
PFA-fixed, Triton X-100 permeabilized human A-431 cells stained for p19 INK4d (green) using ab262871 at 4 µg/ml in ICC/IF.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The p19 protein exerts its effects by tightly binding to CDK4 and CDK6 forming a complex that impedes their kinase activity. This interaction results in the prevention of the phosphorylation of the retinoblastoma protein (pRb) a critical step required for cell cycle progression from G1 to S phase. In doing so p19 INK4d maintains cellular growth control and prevents the transition into unchecked cell division. The regulation of pRb is vital for the prevention of cancerous growth as phosphorylated pRb releases E2F transcription factors that drive S phase entry and DNA synthesis.
Pathways
The activity of p19 INK4d influences the retinoblastoma (Rb) pathway one of the major pathways governing cell cycle control. The Rb pathway regulates the transcriptional repression of E2F target genes associated with cell cycle progression. Besides its interaction with Rb p19 INK4d is also connected with the p53 pathway which oversees cellular responses to DNA damage and stress. This links p19 INK4d indirectly to proteins like the MDM2 and p21 where these pathways intersect to coordinate cell cycle arrest mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature aging 1:1107-1116 PubMed35531351
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com